Clinical Characteristics and Associated Factors for Infection and in-Hospital Mortality in Inpatients with Polymyositis/Dermatomyositis in China: A Retrospective Study

References

• Sara M, Gabriela S, Laura T, et al. A population-based study of infection-related hospital mortality in patients with dermatomyositis/polymyositis. Arthritis Care Res. 2015;67:673–680. doi:10.1002/acr.22501
   Web of Science ®Google Scholar
• Wu C, Wang Q, He L, Yang E, Zeng X. Hospitalization mortality and associated risk factors in patients with polymyositis and dermatomyositis: a retrospective case-control study. PLoS One. 2018;13:e0192491. doi:10.1371/journal.pone.0192491
   PubMed Web of Science ®Google Scholar
• Lundberg IE, Tjärnlund A, Bottai M, et al. 2017 European League Against Rheumatism/American College of Rheumatology classification criteria for adult and juvenile idiopathic inflammatory myopathies and their major subgroups. Ann Rheum Dis. 2017;76:1955–1964. doi:10.1136/annrheumdis-2017-211468
   PubMed Web of Science ®Google Scholar
• Simone B, Maryam D, Antonella N, et al. Performance of the new EULAR/ACR classification criteria for idiopathic inflammatory myopathies (IIM) in a large monocentric IIM cohort. Semin Arthritis Rheum. 2020;50:492–497. doi:10.1016/j.semarthrit.2019.12.001
   PubMed Web of Science ®Google Scholar
• Dongying C, Jingyi X, Haihong C, et al. Infection in Southern Chinese Patients with Systemic Lupus Erythematosus: spectrum, Drug Resistance, Outcomes, and Risk Factors. J Rheumatol. 2016;43:1650–1656. doi:10.3899/jrheum.151523
   PubMed Web of Science ®Google Scholar
• Ben P, Thomas W, Peter D, et al. European Organization for Research and Treatment of Cancer/Invasive Fungal Infections Cooperative Group; National Institute of Allergy and Infectious Diseases Mycoses Study Group (EORTC/MSG) Consensus Group (2008) Revised definitions of invasive fungal disease from the European Organization for Research and Treatment of Cancer/Invasive Fungal Infections Cooperative Group and the National Institute of Allergy and Infectious Diseases Mycoses. Clin Infect Dis. 2008;46:1813–1821. doi:10.1086/588660
   PubMed Web of Science ®Google Scholar
• Scientific working group. The diagnosis and treatment of Candidiasis: the expert consensus. Clin J Infect Chemother. 2011;11:11–95.
   Google Scholar
• Cooley L, Dendle C, Wolf J, et al. Consensus guidelines for diagnosis, prophylaxis and management of Pneumocystis jirovecii pneumonia in patients with haematological and solid malignancies. Intern Med J. 2014;44:1350–1363. doi:10.1111/imj.12599
   PubMed Web of Science ®Google Scholar
• Razonable R, Humar A. Cytomegalovirus in solid organ transplant recipients-guidelines of the American Society of Transplantation Infectious Diseases community of practice. Clin Transplant. 2019;33:e13512. doi:10.1111/ctr.13512
   PubMed Web of Science ®Google Scholar
• Andrew R, Sujith S, Kimme H, James G. Serious infection across biologic-treated patients with rheumatoid arthritis: results from the British Society for Rheumatology Biologics Register for Rheumatoid Arthritis. Ann Rheum Di s. 2018;77:905–910.
   PubMed Web of Science ®Google Scholar
• Nishino M, Itoh H, Hatabu H. A practical approach to high-resolution CT of diffuse lung disease. Eur J Radiol. 2014;83:6–19. doi:10.1016/j.ejrad.2012.12.028
   PubMed Web of Science ®Google Scholar
• Isabelle M, Jean-François M, Eric H, et al. Infectious complications in polymyositis and dermatomyositis: a series of 279 patients. Semin Arthritis Rheum. 2011;41:48–60. doi:10.1016/j.semarthrit.2010.08.003
   PubMed Web of Science ®Google Scholar
• Chen IJ, Tsai WP, Wu YJ, et al. Infections in polymyositis and dermatomyositis: analysis of 192 cases. Rheumatology. 2010;49:2429–2437. doi:10.1093/rheumatology/keq279
   PubMed Web of Science ®Google Scholar
• Yong G, Xiao S, Lin H, Guo W, Xin L. Infection is not rare in patients with idiopathic inflammatory myopathies. Clin Exp Rheumatol. 2022;40:254–259. doi:10.55563/clinexprheumatol/yps7ai
   PubMed Web of Science ®Google Scholar
• Lorenzo C, Ernesto TA, Federica M, et al. Influence of Antisynthetase Antibodies Specificities on Antisynthetase Syndrome Clinical Spectrum Time Course. J Clin Med. 2013;8:2013.
   Google Scholar
• Shi J, Li S, Yang H, et al. Clinical Profiles and Prognosis of Patients with Distinct Antisynthetase Autoantibodies. J Rheumatol. 2017;44:1051–1057. doi:10.3899/jrheum.161480
   PubMed Web of Science ®Google Scholar
• Marie I, Hachulla E, Chérin P, et al. Opportunistic Infections in Polymyositis and Dermatomyositis. Arthritis Rheum. 2005;53:155–165. doi:10.1002/art.21083
   PubMed Web of Science ®Google Scholar
• Marie I, Hachulla E, Hatron PY, et al. Polymyositis and dermatomyositis: short term and longterm outcome, and predictive factors of prognosis. J Rheumatol. 2001;28:2230–2237.
   PubMed Web of Science ®Google Scholar
• Marie I, Hachulla E, Chérin P, et al. Interstitial lung disease in polymyositis and dermatomyositis. Arthritis Rheum. 2002;47:614–622. doi:10.1002/art.10794
   PubMed Web of Science ®Google Scholar
• Wu C, Wang Q, He L, Yang E, Zeng X. Hospitalization mortality and associated risk factors in patients with polymyositis and dermatomyositis: a retrospective case-control study. PLoS One. 2018;13:e0192491.
   PubMed Web of Science ®Google Scholar
• Yang X, Hao Y, Zhang X, et al. Mortality of Chinese patients with polymyositis and dermatomyositis. Clin Rheumatol. 2020;39:1569–1579. doi:10.1007/s10067-019-04910-w
   PubMed Web of Science ®Google Scholar
• Marie I. Morbidity and mortality in adult polymyositis and dermatomyositisX. Curr Rheumatol Rep. 2012;1:275–285. doi:10.1007/s11926-012-0249-3
   Google Scholar
• Dobloug GC, Svensson J, Lundberg IE, Holmqvist M. Mortality in idiopathic inflammatory myopathy: results from a Swedish nationwide population-based cohort study. Ann Rheum Dis. 2018;77:40–47. doi:10.1136/annrheumdis-2017-211402
   PubMed Web of Science ®Google Scholar